HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value

Virchows Archiv : an International Journal of Pathology
An Na SeoHye Seung Lee

Abstract

The clinical and prognostic significance of HER3 expression and its relation to HER2 status in primary colorectal cancer (pCRC) were investigated. We retrospectively analysed 365 consecutive cases of pCRC that had been previously evaluated for HER2 status and included their 143 matched lymph node metastases. Immunohistochemistry (IHC) was performed to assess HER3 expression using tissue array methods. Of 364 eligible patients, HER3 overexpression was detected in 251 cases (69 %) (IHC 2+, n = 186 and IHC 3+, n = 65). HER3 overexpression was inversely correlated with histologic grade (p = 0.006), tumour size (p < 0.001), tumour depth (p < 0.001), TNM stage (p = 0.002), lymphatic invasion (p = 0.004), lymph node metastasis (p = 0.013) and distant metastasis (p = 0.039). Moreover, it positively correlated with both HER2 overexpression (p = 0.007) and HER2 gene amplification (p = 0.006). Although HER3 overexpression was associated with longer survival in univariate analysis (p = 0.026), it was not an independent prognostic factor in multivariate analysis (p = 0.359). Moreover, co-alteration of HER3 and HER2 was associated with neither survival nor any clinicopathologic parameter except tumour location in the rectum. Although not an ...Continue Reading

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Apr 27, 2000·Journal of Cancer Research and Clinical Oncology·S KapitanovićR Spaventi
May 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J C LeeH-B Yang
Dec 14, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Forrest D HsuC Blake Gilks
May 3, 2005·Nature Reviews. Cancer·Nancy E Hynes, Heidi A Lane
Mar 2, 2006·BMC Cancer·Panteleimon KountourakisTheofanis Economopoulos
Aug 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Berno TannerJan Georg Hengstler
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hye Seung LeeWoo Ho Kim
Aug 2, 2007·British Journal of Cancer·A C Hsieh, M M Moasser
Mar 4, 2008·Seminars in Radiation Oncology·David VoducTorsten O Nielsen
Apr 25, 2009·International Journal of Colorectal Disease·Glauco BaiocchiWilson T Nakagawa
Jun 19, 2009·Nature Reviews. Cancer·José Baselga, Sandra M Swain
Dec 19, 2009·The New England Journal of Medicine·Sanford D Markowitz, Monica M Bertagnolli
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Jun 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria D BegnamiFernando A Soares
Dec 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Abdelhamid BejiAxel Ullrich
Dec 14, 2011·The New England Journal of Medicine·José BaselgaUNKNOWN CLEOPATRA Study Group
Dec 30, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian Gespach
Jun 7, 2012·Familial Cancer·Jung Ryul OhJae-Gahb Park
Jul 20, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Dec 1, 2012·Chemotherapy Research and Practice·Ning JiangZhuo Georgia Chen
May 18, 2013·Cancer Cell·Bijay S JaiswalSomasekar Seshagiri
Jul 10, 2013·The Journal of Pathology·Eva BudinskaMauro Delorenzi
Oct 10, 2013·The Journal of Pathology·Filippo Montemurro, Maurizio Scaltriti
Dec 5, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LédelD Edler
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Jan 25, 2018·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Sumi YunHye Seung Lee
Oct 31, 2015·Oncotarget·Yadong WangGuangcai Duan
Aug 10, 2019·Molecular Cancer Therapeutics·Shigehiro KoganemaruToshihiko Doi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Ben-Shun HuJian-Ping Li
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Ji WangDa Pang
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Yanfeng NiuJun Liu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Wei-Xin WangWei-Dong Qi
© 2022 Meta ULC. All rights reserved